All publishers
Sara Talpos, Undark Magazine
ReporterArs TechnicaBeat: Cybersecurity, Open Source, Computing, Regulation, Clinical Trials, FDA, Drug Approval
Observable, documented attributes only. We do not speculate about motives, private beliefs, or personality — patterns are shown with evidence.
Overall rating
Not yet rated. An author is rated after at least 5 of their claims have scored fact-check verdicts.
Bio
Sara Talpos is a writer for Undark Magazine and has contributed to Ars Technica.
Professional background
None provided
Disclosed affiliations
Undark Magazine, Ars Technica
Sourcing patterns
None provided
Reporting vs. opinion history
None provided
Corrections / retractions
None provided
Indexed articles
- The FDA wants to pull its approval of a drug. It’s not so easy.
Oct 31, 2026, 6:02 AM CDT